Harpoon Therapeutics, Inc. (HARP): Price and Financial Metrics
HARP Price/Volume Stats
| Current price | $23.01 | 52-week high | $23.21 |
| Prev. close | $22.99 | 52-week low | $3.11 |
| Day low | $22.99 | Volume | 6,624,300 |
| Day high | $23.02 | Avg. volume | 1,516,200 |
| 50-day MA | $20.95 | Dividend yield | N/A |
| 200-day MA | $10.84 | Market Cap | 389.61M |
HARP Stock Price Chart Interactive Chart >
Harpoon Therapeutics, Inc. (HARP) Company Bio
Harpoon Therapeutics, Inc. develops antibody therapies to treat cancer patients. It develops a novel class of T cell recruiting antibodies against validated hematologic and solid tumor targets. The company founded by Patrick A. Baeuerle and Luke B. Evnin in 2015 and is headquartered in South San Francisco, CA.
Latest HARP News From Around the Web
Below are the latest news stories about HARPOON THERAPEUTICS INC that investors may wish to consider to help them evaluate HARP as an investment opportunity.
Stocks Hold Gains Ahead Of Tuesday's Economic FlurryThe major indexes are continuing their move higher this afternoon, as investors await tomorrow's release of November's consumer price index (CPI) data. |
HARP Price Returns
| 1-mo | N/A |
| 3-mo | 2.72% |
| 6-mo | 422.95% |
| 1-year | 310.01% |
| 3-year | -89.14% |
| 5-year | -79.64% |
| YTD | 102.37% |
| 2023 | 56.68% |
| 2022 | -90.39% |
| 2021 | -54.55% |
| 2020 | 12.31% |
| 2019 | N/A |
Loading social stream, please wait...